Pharmacoeconomic study of the effectiveness of cytogenetic studies in patients with MM before prescribing first-line therapy
Purpose of the study. Conducting an assessment of the economic consequences (clinical and economic analysis) when conducting cytogenetic studies before prescribing various first-line treatment regimens for multiple myeloma (MM). Materialsand methods. The pharmacoeconomic study was carried out using...
Saved in:
Main Authors: | Yu. A. Zabolotneva (Author), I. S. Krysanov (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of anemia therapy in cancer patients in real clinical practice of the Russian Federation
by: I. S. Krysanov, et al.
Published: (2019) -
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
by: I. S. Krysanov, et al.
Published: (2018) -
Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion
by: A. S. Kolbin, et al.
Published: (2018) -
PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015) -
Pharmacoeconomics analysis of pegylated liposomal doxorubicin (Caelyx®) in the treatment of patients with metastatic breast cancer at high risk of cardiac events
by: I. S. Krysanov
Published: (2018)